FDA Releases Plan To Obtain Data Regarding Cannabis-Derived Product Usage & Safety
Cannabis Law Report
NOVEMBER 2, 2021
The plan follows two reports to Congress last year (which the Perkins Coie Cannabis Industry Group has previously written about here and here ) on the safety and labeling of products containing cannabidiol (CBD) and a public statement from outgoing FDA leadership in early 2021 seeking better data for a better understanding of CBD safety.
Let's personalize your content